Sanofi (SNYNF) Return on Equity (2018)

Sanofi's (SNYNF) quarterly Return on Equity came in at 0.0% in Q1 2018.

Sanofi (SNYNF) Return on Equity (2018) Analysis & Trends

Sanofi has disclosed Return on Equity across 1 years of filings, most recently posting 0.0% for Q1 2018.

Return on Equity for Q1 2018 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was 0.0% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
Return on Equity came in at 0.0% for Q1 2018 at Sanofi.
In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2018 to a low of 0.0% in Q1 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROE (Qtr)
1	Gsk	96,436,181.12 Bn	96,436,176.16 Bn	7.76 Bn	-
2	Eli Lilly	1,017.30 Bn	1,012.01 Bn	16.22 Bn	0.01%
3	Johnson & Johnson	579.61 Bn	557.55 Bn	15.96 Bn	0.00%
4	AbbVie	402.30 Bn	392.96 Bn	10.78 Bn	-0.01%
5	Merck	294.24 Bn	288.59 Bn	12.09 Bn	0.00%
6	Amgen	191.82 Bn	179.78 Bn	5.87 Bn	0.01%
7	Gilead Sciences	155.93 Bn	148.21 Bn	5.52 Bn	0.00%
8	Pfizer	149.05 Bn	136.28 Bn	-1.21 Bn	0.00%
9	Bristol Myers Squibb	116.33 Bn	105.88 Bn	8.07 Bn	0.00%
10	Sanofi	-	-	9.49 Bn	-

Historic Data

Download Data

Date	Value
Mar 31, 2018	0.00%